PCBL Chemical Limited has informed the Exchange regarding 'UFR for the Quarter ended 30 June 2025'.
PCBL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
PCBL Chemical reported a soft Q1 FY26 with standalone revenue from operations at Rs 1,452.98 crores, down about 2.6% from Rs 1,491.02 crores in Q1 FY25. Standalone profit after tax fell roughly 20% YoY to Rs 93.09 crores (vs Rs 116.28 crores), with EPS at Rs 2.47 vs Rs 3.08. On a consolidated basis, revenue slipped to Rs 2,114.05 crores (from Rs 2,143.56 crores) and PAT dropped to Rs 94.10 crores (from Rs 117.92 crores). Operating margin compressed sharply to 14.54% (standalone) and 13.85% (consolidated) from 16.89% and 15.64% respectively a year ago. During the quarter, the company issued Rs 100 crores of commercial paper and its subsidiary Nanovace Technologies incorporated a new US-based unit, Nanovace Inc. The statutory auditor (S.R. Batliboi & Co. LLP) issued an unmodified review conclusion on both sets of results.
The year-on-year decline in revenue, profit, and operating margins points to weaker pricing or cost pressure in the quarter, which is likely to be viewed negatively by the market in the near term. However, the clean (unmodified) auditor review, ongoing capacity/voltage expansion into chemicals and battery materials, and manageable debt-equity ratio (0.83 standalone, 1.39 consolidated) limit deeper concerns.